ELAPR002f Injectable Gel

DEVICE3 trials

Sponsors

AbbVie

Conditions

Acne ScarsAtrophic Acne ScarsSkin Quality Deficit

Phase 2

A Study to Evaluate the Safety and Effectiveness of ELAPR002f Injectable Gel for the Improvement of Skin Quality in Adult Participants

CompletedNCT06151535

AbbVieSkin Quality Deficit

Start: 2023-12-19End: 2025-02-24Updated: 2025-03-05

Phase 3

ELAPR002f Injectable Gel in the Treatment of Atrophic Acne Scars

Active, not recruitingNCT05995340

AbbVieAtrophic Acne Scars

Start: 2023-11-21End: 2026-08-31Updated: 2025-06-06

A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars

RecruitingNCT07207369

AbbVieAcne Scars

Start: 2025-10-24End: 2029-11-30Target: 395Updated: 2025-11-24